Anika Therapeutics, Inc. Share-based Payment Arrangement, Decrease for Tax Withholding Obligation
Anika Therapeutics, Inc. (ANIK) reported Share-based Payment Arrangement, Decrease for Tax Withholding Obligation of $57.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes
us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-07-29
- Anika Therapeutics, Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-06-30 was $57.00K, a 31.33% decline year-over-year.
- Anika Therapeutics, Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-03-31 was $1.66M, a 13.02% increase year-over-year.
- Anika Therapeutics, Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2025-09-30 was $13.00K, a 38.10% decline year-over-year.
- Anika Therapeutics, Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2025-06-30 was $83.00K, a 59.71% decline year-over-year.
- Anika Therapeutics, Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2025 was $1.57M, a 39.71% decline from fiscal 2024.
- Anika Therapeutics, Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2024 was $2.60M, a 20.77% increase from fiscal 2023.
- Anika Therapeutics, Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2023 was $2.15M, a 130.41% increase from fiscal 2022.
- Anika Therapeutics, Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2022 was $934.00K, a 92.18% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 3 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 6 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 9 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $57.00K 10-Q · filed 2026-07-29 | $1.72M derived: sum of 2 quarters · filed 2026-07-29 | ||
| 2026-03-31 | $1.66M 10-Q · filed 2026-07-29 | |||
| 2025-12-31 | $1.57M 10-K · filed 2026-03-03 | |||
| 2025-09-30 | $13.00K 10-Q · filed 2025-11-05 | $96.00K derived: sum of 2 quarters · filed 2026-07-29 | $1.56M derived: sum of 3 quarters · filed 2026-07-29 | |
| 2025-06-30 | $83.00K 10-Q · filed 2026-07-29 | $1.55M derived: sum of 2 quarters · filed 2026-07-29 | ||
| 2025-03-31 | $1.47M 10-Q · filed 2026-07-29 | |||
| 2024-12-31 | $2.60M 10-K · filed 2026-03-03 | |||
| 2024-09-30 | $21.00K 10-Q · filed 2025-11-05 | $227.00K derived: sum of 2 quarters · filed 2025-11-05 | $2.52M derived: sum of 3 quarters · filed 2025-11-05 | |
| 2024-06-30 | $206.00K 10-Q · filed 2025-11-05 | $2.50M derived: sum of 2 quarters · filed 2025-11-05 | ||
| 2024-03-31 | $2.30M 10-Q · filed 2025-11-05 | |||
| 2023-12-31 | $2.15M 10-K · filed 2026-03-03 | |||
| 2023-09-30 | $107.00K 10-Q · filed 2024-11-04 | $539.00K derived: sum of 2 quarters · filed 2024-11-04 | $2.16M derived: sum of 3 quarters · filed 2024-11-04 | |
| 2023-06-30 | $432.00K 10-Q · filed 2024-11-04 | $2.05M derived: sum of 2 quarters · filed 2024-11-04 | ||
| 2023-03-31 | $1.62M 10-Q · filed 2024-11-04 | |||
| 2022-12-31 | $934.00K 10-K · filed 2025-03-17 | |||
| 2022-09-30 | $66.00K 10-Q · filed 2023-11-03 | $91.00K derived: sum of 2 quarters · filed 2023-11-03 | $935.00K derived: sum of 3 quarters · filed 2023-11-03 | |
| 2022-06-30 | $25.00K 10-Q · filed 2023-11-03 | $869.00K derived: sum of 2 quarters · filed 2023-11-03 | ||
| 2022-03-31 | $844.00K 10-Q · filed 2023-11-03 | |||
| 2021-12-31 | $486.00K 10-K · filed 2024-03-15 | |||
| 2021-09-30 | $71.00K 10-Q · filed 2022-11-09 | $90.00K derived: sum of 2 quarters · filed 2022-11-09 | $423.00K derived: sum of 3 quarters · filed 2022-11-09 | |
| 2021-06-30 | $19.00K 10-Q · filed 2022-11-09 | $352.00K derived: sum of 2 quarters · filed 2022-11-09 | ||
| 2021-03-31 | $333.00K 10-Q · filed 2022-11-09 | |||
| 2020-12-31 | $262.00K 10-K · filed 2023-03-16 | |||
| 2020-09-30 | $24.00K 10-Q · filed 2021-11-05 | $83.00K derived: sum of 2 quarters · filed 2021-11-05 | $224.00K derived: sum of 3 quarters · filed 2021-11-05 | |
| 2020-06-30 | $59.00K 10-Q · filed 2021-11-05 | $200.00K derived: sum of 2 quarters · filed 2021-11-05 | ||
| 2020-03-31 | $141.00K 10-Q · filed 2021-11-05 | |||
| 2019-12-31 | $293.00K 10-K · filed 2022-03-11 | |||
| 2019-09-30 | $120.00K 10-Q · filed 2020-11-05 | |||
| 2019-03-31 | $124.00K 10-Q · filed 2020-11-05 | |||
| 2018-12-31 | $1.79M 10-K/A · filed 2021-04-26 | |||
| 2018-03-31 | $1.74M 10-Q · filed 2019-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |